| Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines RH Jácomo, RAM Melo, FR Souto, ER de Mattos, CT de Oliveira, ... haematologica 92 (10), 1431-1432, 2007 | 157 | 2007 |
| Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL EM Rego, HT Kim, GJ Ruiz-Argüelles, MS Undurraga, MR Uriarte, ... Blood, The Journal of the American Society of Hematology 121 (11), 1935-1943, 2013 | 143 | 2013 |
| Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and … AR Lucena-Araujo, HT Kim, RH Jacomo, RA Melo, R Bittencourt, ... Annals of hematology 93, 2001-2010, 2014 | 67 | 2014 |
| p53, Mdm2, and c‐Myc overexpression is associated with a poor prognosis in aggressive non‐Hodgkin's lymphomas KBB Pagnano, J Vassallo, I Lorand‐Metze, FF Costa, STO Saad American journal of hematology 67 (2), 84-92, 2001 | 62 | 2001 |
| Current patient management of chronic myeloid leukemia in Latin America: a study by the Latin American Leukemia Net (LALNET) J Cortes, C De Souza, M Ayala‐Sanchez, I Bendit, C Best‐Aguilera, ... Cancer 116 (21), 4991-5000, 2010 | 54 | 2010 |
| Adherence to tyrosine kinase inhibitor therapy for chronic myeloid leukemia: a Brazilian single-center cohort MH de Almeida, KBB Pagnano, AC Vigorito, I Lorand-Metze, ... Acta haematologica 130 (1), 16-22, 2013 | 51 | 2013 |
| Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale HE White, J Hedges, I Bendit, S Branford, D Colomer, A Hochhaus, ... Clinical chemistry 59 (6), 938-948, 2013 | 50 | 2013 |
| High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia AR Lucena-Araujo, HT Kim, C Thomé, RH Jacomo, RA Melo, ... Blood, The Journal of the American Society of Hematology 126 (20), 2302-2306, 2015 | 41 | 2015 |
| Influence of BCR-ABL transcript type on outcome in patients with chronic-phase chronic myeloid leukemia treated with imatinib KBB Pagnano, EC Miranda, MT Delamain, GO Duarte, EV de Paula, ... Clinical Lymphoma Myeloma and Leukemia 17 (11), 728-733, 2017 | 40 | 2017 |
| Mutations in the p53 gene in acute myeloid leukemia patients correlate with poor prognosis MB Melo, NN Ahmad, CSP Lima, KBB Pagnano, S Bordin, I Lorand-Metze, ... Hematology 7 (1), 13-19, 2002 | 40 | 2002 |
| Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience KBB Pagnano, F Traina, T Takahashi, GB Oliveira, MS Rossini, ... São Paulo Medical Journal 118, 173-178, 2000 | 39 | 2000 |
| All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA … MA Sanz, P Montesinos, HT Kim, GJ Ruiz-Argueelles, MS Undurraga, ... Annals of hematology 94, 1347-1356, 2015 | 36 | 2015 |
| Apoptosis-regulating proteins and prognosis in diffuse large B cell non-Hodgkin’s lymphomas KBB Pagnano, MD Silva, J Vassallo, FJP Aranha, STO Saad Acta haematologica 107 (1), 29-34, 2002 | 33 | 2002 |
| Philadelphia-negative chronic myeloproliferative neoplasms RI Bittencourt, J Vassallo, MLLF Chauffaille, SG Xavier, KB Pagnano, ... Revista Brasileira de Hematologia e Hemoterapia 34, 140-149, 2012 | 32 | 2012 |
| COVID-19 in patients (pts) with chronic myeloid leukemia (CML): results from the international CML foundation (iCMLf) CML and COVID-19 (CANDID) study D Rea, MJ Mauro, JE Cortes, Q Jiang, KB Pagnano, M Ongondi, CH Kok, ... Blood 136, 46-47, 2020 | 28 | 2020 |
| Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia AR Lucena-Araujo, JL Coelho-Silva, DA Pereira-Martins, DR Silveira, ... Blood, The Journal of the American Society of Hematology 134 (12), 951-959, 2019 | 28 | 2019 |
| Frontline therapy with early intensification and autologous stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non-Hodgkin’s … RC Baldissera, M Nucci, AC Vigorito, A Maiolino, BP Simões, ... Acta haematologica 115 (1-2), 15-21, 2006 | 28 | 2006 |
| Guidelines on the diagnosis and treatment for acute promyelocytic leukemia: associação brasileira de hematologia, hemoterapia e terapia celular guidelines project: associação … KBB Pagnano, EM Rego, S Rohr, ML Chauffaille, RH Jacomo, ... Revista brasileira de hematologia e hemoterapia 36, 71-92, 2014 | 27 | 2014 |
| Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors-a single center … BF Ribeiro, ECM Miranda, DM Albuquerque, MT Delamain, ... Clinics 70 (8), 550-555, 2015 | 26 | 2015 |
| Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients—An analysis from the Brazilian Hodgkin Lymphoma Registry I Biasoli, N Castro, M Delamain, T Silveira, J Farley, B Pinto Simões, ... International journal of cancer 142 (5), 883-890, 2018 | 25 | 2018 |
